Results 241 to 250 of about 304,614 (388)

Endothelin-A-Receptor Antagonist LU 135.252 Inhibits the Formation of Ventricular Arrhythmias Caused By Intrapericardial Infusion of Endothelin-1

, 2000
Orsolya Kiss, Lászl Gellér, Béla Merkely, Tamás Szabó, Manfred Raschack, Leila Seres, Endre Zima, Alexander Juhász‐Nagy, Ferenc Horkay   +8 more
openalex   +1 more source

Effects of L-749,329, an ET_A/ET_BEndothelin Receptor Antagonist, in a Porcine Coronary Artery Injury Model of Vascular Restenosis [PDF]

, 2001
William R. Huckle, Marlene Drag, Wayne R. Acker, Michele Powers, Rosemary C. McFall, Daniel Holder, Thomas F. Walsh, Robert S. Schwartz, William J. Greenlee, Robert G. Johnson   +9 more
openalex   +1 more source

Can Combination Therapy with Endothelin Receptor Antagonist and PDE5 Inhibitors Prevent Echocardiographic Findings Suspicious for Pulmonary Arterial Hypertension? Description of a Real-Life Case Series. [PDF]

Diagnostics (Basel)
Damiani A, Lepri G, Bonomi F, Fiorentini E, Peretti S, Blagojevic J, Bellando Randone S, Guiducci S.   +7 more
europepmc   +1 more source

Biotransformation of Ambrisentan by A. niger and P. mineoluteum Monitored by High Performance Liquid Chromatography and Ultra High Performance Liquid Chromatography/Quadrupole Time‐of‐Flight Mass Spectrometry

SEPARATION SCIENCE PLUS, Volume 8, Issue 6, June 2025.
ABSTRACT The focus of the present study was the monitoring of ambrisentan (AMB) in vitro biotransformation by two fungal cultures: Aspegillus niger ATCC 9029 and Penicillium mineoluteum URM 6889. This drug is a selective endothelin Type A, receptor antagonist, used for pulmonary arterial hypertension.
Rafaela Martins Sponchiado, Brendha Lang Camboim, Julia Medeiros Sorrentino, Leticia Cordenonsi, Alexsandro Dallegrave, Alexandre Meneghello Fuentefria, Martin Steppe, Cássia Virginia Garcia   +7 more
wiley   +1 more source

ADDITION OF AN ENDOTHELIN RECEPTOR ANTAGONIST TO MODIFIED BELZERʼS HYPOTHERMIC PERFUSION PRESERVATION SOLUTION MITIGATES THE ADVERSE EFFECT OF PRE-RETRIEVAL WARM ISCHEMIC INJURY ON GLOMERULAR FILTRATION RATE FOLLOWING RENAL TRANSPLANTATION.

, 2000
Sharon R. Inman, Thomas E. Burns, Wanda K. Plott, Ray A. Pomilee, Jodi Antonelli, Richard M. Lewis   +5 more
openalex   +1 more source

Chronic Effects of an Orally Active Selective Endothelin-B-Receptor Antagonist in Experimental Congestive Heart Failure

, 2000
Masahide Sawaki, Atsuyuki Wada, Takayoshi Tsutamoto, Masato Ohnishi, Masanori Fujii, Takehiro Matsumoto, Masahiko Kinoshita   +6 more
openalex   +1 more source

Pretreatment of Donors with Endothelin Receptor Antagonist TAK-044 Improves Cardiac Functional Recovery Following Preservation with University of Wisconsin Solution [PDF]

, 2002
Toshio Kaneda, Zhiwei Zhang, Tatsuya Ogawa, Masaki Otaki, Toshihiko Saga   +4 more
openalex   +1 more source

The Clinical Course of Portopulmonary Hypertension and Outcomes With Endothelin Receptor Antagonist Treatment: Observational Study of Data From the US Organ Procurement and Transplantation Network. [PDF]

Transplant Direct
DuBrock HM, Jose A, Arendse S, Martin N, Studer S, Rosenberg D.   +5 more
europepmc   +1 more source

Rare but relevant: The injection of tablet preparations and pulmonary hypertension

Addiction, Volume 120, Issue 6, Page 1276-1279, June 2025.
Abstract Intravascular injection of dissolved medicinal preparations such as crushed tablets is associated with a risk of injecting particulate material into the vasculature. This particulate material will naturally pass to the lungs where it will be largely filtered out in the pulmonary vascular bed, and in turn, it can result in a range of ...
Johan Duflou
wiley   +1 more source

Bosentan, an endothelin receptor antagonist, augments graft function by reducing graft circulatory impairment following ischemia reperfusion

, 2000
Rocco Ricciardi, Bradley K. Schaffer, Shimul A. Shah, Steven H. Quarfordt, Barbara F. Banner, Ravi S. Chari, William C. Meyers   +6 more
openalex   +1 more source